▲ +7.14% Upside Potential
This price target is based on 16 analysts offering 12 month price targets for ACADIA Pharmaceuticals in the last 3 months. The average price target is $60.00, with a high forecast of $72.00 and a low forecast of $42.00. The average price target represents a 7.14% upside from the last price of $56.00.
The current consensus among 16 contributing investment analysts is to buy stock in ACADIA Pharmaceuticals. This Buy consensus rating has held steady for over two years.